Metrion Biosciences (‘Metrion’) is a UK-based, ion channel focused Contract Research Organisation (CRO) providing high-quality in vitro preclinical drug discovery and safety profiling services. Formed in 2015, Metrion has since established a loyal and growing global customer base who access our comprehensive suite of drug discovery services; including medicinal chemistry screening support, cardiac safety profiling and custom assays using native tissue and stem cells.
Scientist, Cell Biology Research
at Bit Bio
bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.
About the Role
The Senior Commercialisation Manager is an important position in the Biopharma team of QMI, who will manage a highly varied portfolio of projects principally from the Barts and London School of Medicine and Dentistry. You will seek out new opportunities, evaluate commercial value and working with our reserachers develop and implement commercialization strategies. You will work with a variety of stakeholders including academics, funders, licensees and investors.
We are a global leader in the development and manufacturing of active pharmaceutical ingredients, focused on specialist niches with expertise in highly regulated and complex chemistries. Formerly part of Johnson Matthey, we have over 50 years of experience navigating the challenges of the global healthcare industry, and nurturing long-standing, trusted customer relationships. Operating within two divisions, Generics and Originators, we deliver a differentiated service offering to pharma and biotech customers for every stage in the drug development lifecycle.
To provide support to ensure that the facility and laboratory runs smoothly and safely so that scientists and support staff can perform their day-to-day duties with minimal disruption. Maintain facility through existing contractor relationships whilst continually evaluating whether established third party providers are suitable and sufficient. Plan, schedule, manage & organize facilities renovations, reorganizations & installations of new infrastructure, equipment & services.
At LifeArc, we want to hear from people who are as passionate as we are about making life science life changing that can improve patients’ lives.
Subject Matter Expert – Protein Science
£65,000 - £85,000 + Bonus + Excellent Benefits
Are you an expert in using cell-free protein synthesis (CFPS)?
Would you like to work for an exciting early-stage biotechnology company, supporting their novel assay platforms?
Optimum is a leader in strategic communications for healthcare and life sciences industry. We are looking for a motivated, smart Financial PR Account Manager with excellent written and spoken communications skills to join our expanding entrepreneurial healthcare team. You will be working with one of the most talented and experienced teams in the industry, which combine investor relations and sector expertise. You will have the opportunity to fast track your career and experience by working closely with world class companies which are leaders in their respective fields.
Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of neurodegenerative disease, rare mitochondrial diseases and fibrosis. The Company has built a leading platform for the discovery and development of first-in-class, small molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging drug class that is attracting significant commercial interest in the area of protein homeostasis.
Sania Therapeutics (Sania Rx, Ltd) is hiring an electrophysiologist to accelerate development of novel gene therapies for neurological disorders. Sania is an innovative new biotech company aiming to revolutionize the treatment of neurological disorders by developing the next generation of highly targeted gene therapies.